Used as main image by Phynd in search results and profile page

Angelos Halaris, MD, PhD

Psychiatry

Speaks

Languages

German
Greek

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

630-653-6441
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
630-653-6441

Services & Specialties

Areas of Specialization

  • Psychiatry

Locations & Contact

Primary Location

Genesis Clinical Services

1725 S Naperville Rd
Wheaton , IL 60189

About

Academic Title

Professor

Ages Seen

Adults - Over 65
Adults - 18 to 64

Additional Resources

Education & Certifications

Education

Education:
Ludwig-Maximilians Universitat (1967)

Fellowship:
University of Chicago Medical Center (Illinois) (1977)

Board Certifications

Psychiatry, Psychiatry, American Board of Psychiatry & Neurology (1981)

Psychiatry, Psychiatry, American Board of Psychiatry and Neurology (1981)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Publications

  • IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions. Shkundin, A.; Halaris, A.; Journal of personalized medicine
  • The Impact of Mindfulness-Based Interventions on Objective Physiological Measures of Autonomic Function for Individuals With Medical Conditions: A Review of the Evidence. Churchill, R.; Swartz, B.; Johnston-Dumerauf, A.; Halaris, A.; Psychosomatic medicine
  • Systemic Inflammatory Response Index (SIRI) at Baseline Predicts Clinical Response for a Subset of Treatment-Resistant Bipolar Depressed Patients. Murata, S.; Baig, N.; Decker, K.; Halaris, A.; Journal of personalized medicine
  • Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder. Shkundin, A.; Halaris, A.; Journal of personalized medicine
  • The Possible Role of NLRP3 Inflammasome in Depression and Myocardial Infarction Comorbidity. Baysak, E.; Yildirim, C.; Sayar, N.; Sayar, M. K.; Halaris, A.; Aricioglu, F.; Journal of personalized medicine
  • Utilizing the Systemic Immune-Inflammation Index and Blood-Based Biomarkers in Association with Treatment Responsiveness amongst Patients with Treatment-Resistant Bipolar Depression. Decker, K.; Murata, S.; Baig, N.; Hasan, S.; Halaris, A.; Journal of personalized medicine
  • Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depression. Halaris, A.; Hain, D.; Law, R.; Brown, L.; Lewis, D.; Filip, M.; Brain, behavior, & immunity - health
  • The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation? Halaris, A.; Cook, J.; Advances in experimental medicine and biology
  • Cardiolipin Antibody: A Potential Biomarker for Depression. Costa, R.; Fatourou, E.; Hoppensteadt, D.; Fareed, J.; Halaris, A.; Journal of personalized medicine
  • Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression. Cook, J.; Halaris, A.; Progress in neuro-psychopharmacology & biological psychiatry
  • Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders. Myint, A. M.; Halaris, A.; Frontiers in psychiatry
  • Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders. Bliźniewska-Kowalska, K.; Gałecki, P.; Su, K. P.; Halaris, A.; Szemraj, J.; Gałecka, M.; Journal of clinical medicine
  • Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression? Gałecka, M.; Szemraj, J.; Su, K. P.; Halaris, A.; Maes, M.; Skiba, A.; Gałecki, P.; Bliźniewska-Kowalska, K.; Journal of clinical medicine
  • Autonomic Measures in Differentiating Depressive Disorders: A Potential AID. Guccione, C.; Heilman, K.; Porges, S. W.; Gentile, S.; Caretti, V.; Halaris, A.; Clinical neuropsychiatry
  • Vitamin D Supplementation for the Treatment of Depressive Symptoms in Women with Type 2 Diabetes: A Randomized Clinical Trial. Penckofer, S.; Ridosh, M.; Adams, W.; Grzesiak, M.; Woo, J.; Byrn, M.; Kouba, J.; Sheean, P.; Kordish, C.; Durazo-Arvizu, R.; Wallis, D.; Emanuele, M. A.; Halaris, A.; Journal of diabetes research
  • Pharmacogenetic Testing in an Academic Psychiatric Clinic: A Retrospective Chart Review. Brown, L.; Li, J.; Katel, N.; Yu, K.; Fatourou, E.; Himmler, B.; Halaris, A.; Journal of personalized medicine
  • C-reactive protein as a potential biomarker in psychiatric practice: Are we there yet? Baysak, E.; Guden, D. S.; Aricioglu, F.; Halaris, A.; The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • A Review of the Global Impact of the COVID-19 Pandemic on Public Mental Health, with a Comparison Between the USA, Australia, and Poland with Taiwan and Thailand. Bliźniewska-Kowalska, K. M.; Halaris, A.; Wang, S. C.; Su, K. P.; Maes, M.; Berk, M.; Gałecki, P.; Medical science monitor : international medical journal of experimental and clinical research
  • Treatment-Resistant Depression Revisited: A Glimmer of Hope. Halaris, A.; Sohl, E.; Whitham, E. A.; Journal of personalized medicine
  • Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. Edberg, D.; Hoppensteadt, D.; Walborn, A.; Fareed, J.; Sinacore, J.; Halaris, A.; Journal of psychiatric research
  • Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction. Castillo, M. F. R.; Cohen, A.; Edberg, D.; Hoppensteadt, D.; Fareed, J.; Martin, B.; Halaris, A.; Psychiatry research
  • Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depression. Murata, S.; Murphy, M.; Hoppensteadt, D.; Fareed, J.; Welborn, A.; Halaris, A.; Brain, behavior, and immunity
  • Experience Of Resident Presentations In Consultation-Liaison Psychiatry Grand Rounds: Increase Value For Clinical Education. Meresh, E. S.; Daniels, D.; Rao, M.; Sharma, A.; Halaris, A.; Schilling, D.; Advances in medical education and practice
  • Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Pollak, T. A.; Lennox, B. R.; Müller, S.; Benros, M. E.; Prüss, H.; Tebartz van Elst, L.; Klein, H.; Steiner, J.; Frodl, T.; Bogerts, B.; Tian, L.; Groc, L.; Hasan, A.; Baune, B. T.; Endres, D.; Haroon, E.; Yolken, R.; Benedetti, F.; Halaris, A.; Meyer, J. H.; Stassen, H.; Leboyer, M.; Fuchs, D.; Otto, M.; Brown, D. A.; Vincent, A.; Najjar, S.; Bechter, K.; The lancet. Psychiatry
  • Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial. Halaris, A.; Cantos, A.; Johnson, K.; Hakimi, M.; Sinacore, J.; Journal of affective disorders
  • Inflammation and depression but where does the inflammation come from? Halaris, A.; Current opinion in psychiatry
  • Metabolic Syndrome Reversal With Cariprazine. Halaris, A.; Wuest, J.; Journal of clinical psychopharmacology
  • Obstructive sleep apnea co-morbidity in patients with fibromyalgia: a single-center retrospective analysis and literature review. Meresh, E. S.; Artin, H.; Joyce, C.; Birch, S.; Daniels, D.; Owens, J. H.; La Rosa, A. J.; Rao, M. S.; Halaris, A.; Open access rheumatology : research and reviews
  • Serotonin Syndrome Following Septal Myectomy in Association With Fentanyl and Methylene Blue: A Case Report. Haacker, L.; Maliekel, M.; Bardsley, C. E. H.; Bergren, R.; Meresh, E.; Halaris, A.; Psychosomatics
  • Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. Edberg, D.; Hoppensteadt, D.; Walborn, A.; Fareed, J.; Sinacore, J.; Halaris, A.; Journal of psychiatric research
  • Diminution of Heart Rate Variability in Bipolar Depression. Hage, B.; Britton, B.; Daniels, D.; Heilman, K.; Porges, S. W.; Halaris, A.; Frontiers in public health
  • Low cardiac vagal tone index by heart rate variability differentiates bipolar from major depression. Hage, B.; Britton, B.; Daniels, D.; Heilman, K.; Porges, S. W.; Halaris, A.; The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease. Halaris, A.; Current topics in behavioral neurosciences
  • Vascular endothelial growth factor: Potential predictor of treatment response in major depression. Clark-Raymond, A.; Meresh, E.; Hoppensteadt, D.; Fareed, J.; Sinacore, J.; Garlenski, B.; Halaris, A.; The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • Does escitalopram reduce neurotoxicity in major depression? Halaris, A.; Myint, A. M.; Savant, V.; Meresh, E.; Lim, E.; Guillemin, G.; Hoppensteadt, D.; Fareed, J.; Sinacore, J.; Journal of psychiatric research
  • Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings. Doyle, T.; Halaris, A.; Rao, M.; Current diabetes reports
  • Vascular Endothelial Growth Factor: a potential diagnostic biomarker for major depression. Clark-Raymond, A.; Meresh, E.; Hoppensteadt, D.; Fareed, J.; Sinacore, J.; Halaris, A.; Journal of psychiatric research
  • Medical students' interest in pursuing psychiatry residency: a 5-year analysis of a consultation psychiatry clerkship educational module. Meresh, E.; Rao, M.; Schilling, D.; Niedzwiecki, M.; Halaris, A.; Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
  • Psychocardiology: moving toward a new subspecialty. Halaris, A.; Future cardiology
  • Inflammation, heart disease, and depression. Halaris, A.; Current psychiatry reports
  • VEGF and depression: a comprehensive assessment of clinical data. Clark-Raymond, A.; Halaris, A.; Journal of psychiatric research
  • Co-morbidity between cardiovascular pathology and depression: role of inflammation. Halaris, A.; Modern trends in pharmacopsychiatry
  • A primary care focus on the diagnosis and treatment of major depressive disorder in adults. Halaris, A.; Journal of psychiatric practice
  • Pro-inflammatory biomakers in depression: treatment with venlafaxine. Piletz, J. E.; Halaris, A.; Iqbal, O.; Hoppensteadt, D.; Fareed, J.; Zhu, H.; Sinacore, J.; Devane, C. L.; The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • Agmatine : metabolic pathway and spectrum of activity in brain. Halaris, A.; Plietz, J.; CNS drugs
  • Platelet imidazoline receptors as state marker of depressive symptomatology. Piletz, J.; Baker, R.; Halaris, A.; Journal of psychiatric research